About this policy
The comment period for the: MolDX: Breast Cancer Index ® (BCI) Gene Expression Test DL37794 Local Coverage Determination (LCD) began on 04/23/2020 and ended on 07/07/2020. The notice period for L37794 begins on 3/18/21 and will become effective on 5/2/21. The comments below were received from the provider community.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.